Brief: Cipla Receives U.S. FDA Approval For First AB-Rated Generic Of Ventolin® Hfa
23/04/2026 16:25
April 23 (Reuters) - Cipla Ltd CIPL.NS: CIPLA RECEIVES U.S. FDA APPROVAL FOR FIRST AB-RATED GENERIC OF VENTOLIN® HFA Source text: ID:nPn7l5ygca Further company coverage: CIPL.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Cipla
See all newsIndian pharma stocks up on report US taps drugmakers for critical cancer drug
India's Cipla jumps after Citi sees near-term positive triggers for earnings
Factbox: Global drugmakers invest billions to boost US presence
India raises price cap on cancer drugs to tackle shortage
Brief: Cipla Says USFDA Classified Verna Manufacturing Facility Inspection As Voluntary Action Indicated